Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder
Rafael G. dos Santos, Flávia de Lima Osório, Juliana Mendes Rocha, et al.
Journal of Clinical Psychopharmacology (2021) Vol. 41, Iss. 5, pp. 540-550
Closed Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review
Joost J. Breeksema, Bouwe Kuin, Jeanine Kamphuis, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 10, pp. 1100-1117
Open Access | Times Cited: 132
Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis
Yuan Yao, Dan Guo, Tangsheng Lu, et al.
Psychiatry Research (2024) Vol. 335, pp. 115886-115886
Closed Access | Times Cited: 30
The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics
Ricarda Evens, Marianna E. Schmidt, Tomislav Majić, et al.
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 26
Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review
Bruno Roméo, E. Kervadec, Baptiste Fauvel, et al.
Psychiatry Research (2024) Vol. 335, pp. 115880-115880
Closed Access | Times Cited: 14
Exploring Gender-Themed Lysergic Acid Diethylamide Experiences: A Subreddit Analysis
Rahul Katkar, Ashley M. Perez, Murat Altinay, et al.
Psychedelic Medicine (2025)
Closed Access | Times Cited: 1
Exploring Serotonergic Psychedelics as a Treatment for Personality Disorders
Brennan M. Carrithers, Daniel E. Roberts, Brandon Weiss, et al.
Neuropharmacology (2025), pp. 110413-110413
Closed Access | Times Cited: 1
Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
Molecules (2022) Vol. 27, Iss. 8, pp. 2520-2520
Open Access | Times Cited: 34
A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions
Bill Brennan, Alex R. Kelman, Alexander B. Belser
Psychedelic Medicine (2023) Vol. 1, Iss. 4, pp. 218-229
Open Access | Times Cited: 22
Ayahuasca: A review of historical, pharmacological, and therapeutic aspects
Simon Ruffell, Max Crosland‐Wood, Rob Palmer, et al.
Psychiatry and Clinical Neurosciences Reports (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 17
In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials
Paul Soliman, Dallece E. Curley, Christy Capone, et al.
Psychopharmacology (2024) Vol. 241, Iss. 6, pp. 1101-1110
Closed Access | Times Cited: 8
Ayahuasca's therapeutic potential: What we know – and what not
Lucas Oliveira Maia, Dimitri Daldegan‐Bueno, Isabel Wießner, et al.
European Neuropsychopharmacology (2022) Vol. 66, pp. 45-61
Closed Access | Times Cited: 28
Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors
Polina Ponomarenko, Federico Seragnoli, Abigail E. Calder, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 660-678
Open Access | Times Cited: 15
Psychotherapeutic and neurobiological processes associated with ayahuasca: A proposed model and implications for therapeutic use
Daniel Perkins, Simon Ruffell, Kimberley Day, et al.
Frontiers in Neuroscience (2023) Vol. 16
Open Access | Times Cited: 14
Who are you after psychedelics? A systematic review and a meta-analysis of the magnitude of long-term effects of serotonergic psychedelics on cognition/creativity, emotional processing and personality
Ivana Solaja, Kate Haldane, Natasha L. Mason, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 158, pp. 105570-105570
Closed Access | Times Cited: 6
The current state of ayahuasca research in animal models: A systematic review
Dimitri Daldegan‐Bueno, Natália Maria Simionato, Vanessa Manchim Favaro, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 125, pp. 110738-110738
Open Access | Times Cited: 11
A Systematic Review of Study Design and Placebo Controls in Psychedelic Research
Alexander Wen, Nikhita Singhal, Brett D. M. Jones, et al.
Psychedelic Medicine (2023) Vol. 2, Iss. 1, pp. 15-24
Closed Access | Times Cited: 11
Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant
Giordano Novak Rossi, Lorena T. L. Guerra, Glen B. Baker, et al.
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1618-1618
Open Access | Times Cited: 17
Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis
John R. Kelly, Gerard Clarke, Andrew Harkin, et al.
International Journal of Clinical and Health Psychology (2022) Vol. 23, Iss. 2, pp. 100349-100349
Open Access | Times Cited: 17
Effects of a Single Dose of Ayahuasca in College Students With Harmful Alcohol Use
Lucas Silva Rodrigues, José Augusto Silva Reis, Giordano Novak Rossi, et al.
Journal of Clinical Psychopharmacology (2024)
Closed Access | Times Cited: 3
Serotonergic psychedelics as potential therapeutics for post-COVID-19 syndrome (or Long COVID): A comprehensive review
Zhen Xuen Brandon Low, Shin Jie Yong, Hayam A Alrasheed, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111279-111279
Closed Access
The Effects of Psychedelic-Assisted Therapy on Illness and Death Anxiety: A Systematic Review and Meta-Analysis
Aron Amaev, Jianmeng Song, Yasaman Kambari, et al.
Journal of Psychiatric Research (2025)
Closed Access
Pictorial representation of illness and self measure (PRISM): A putative transdiagnostic tool for evaluating therapeutic effects of psychedelic treatments
Niloufar Pouyan, Jacob S. Aday, Steven E. Harte, et al.
Journal of Psychopharmacology (2025)
Closed Access
A new insight into ayahuasca’s adverse effects: Reanalysis and perspectives on its mediating role in mental health from the Global Ayahuasca Survey (GAS)
Óscar Andión, José Carlos Bouso, Jerome Sarris, et al.
PLOS mental health. (2025) Vol. 2, Iss. 4, pp. e0000097-e0000097
Open Access
Set and setting of psychedelics for therapeutic use in psychiatry: A systematic review
Clémentine Estric, Thomas Duron, Sarah Kabani, et al.
Journal of Psychopharmacology (2025)
Closed Access
Ayahuasca and Public Health II: Health Status in a Large Sample of Ayahuasca-Ceremony Participants in the Netherlands
Maja Kohek, Genís Oña, Michiel van Elk, et al.
Journal of Psychoactive Drugs (2022) Vol. 55, Iss. 3, pp. 247-258
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top